CN113583189A

CN113583189A - Polyhydroxy polyurethane protein transfection reagent, preparation method and application thereof

Info

Publication number: CN113583189A
Application number: CN202110900359.4A
Authority: CN
Inventors: 李全顺; 梁骁; 温凯; 姜伟; 陈英翾; 韩浩博
Original assignee: Jilin University
Current assignee: Jilin University
Priority date: 2021-08-06
Filing date: 2021-08-06
Publication date: 2021-11-02
Anticipated expiration: 2041-08-06
Also published as: CN113583189B

Abstract

A polyhydroxy polyurethane protein transfection reagent constructed based on enzymatic chemical coupling, a preparation method and application thereof in transfection of proteins with molecular weight of 10-450 kDa belong to the technical field of biology. According to the invention, a polyurethane carrier material is prepared by a mode of coupling enzymatic ring-opening polymerization and polycondensation reaction, and the polyurethane material is further modified and modified by utilizing atom transfer radical polymerization reaction to construct a polyhydroxy polyurethane protein transfection reagent. The human cervical carcinoma cell HeLa is taken as a target cell, and the assembly capacity and the transfection efficiency of the prepared transfection reagent and protein are systematically evaluated. The results show that the transfection reagent can form stable nano-complexes with proteins and successfully transfect proteins with different molecular weights into cells, and simultaneously maintain the structure and biological activity of the proteins.

Description

Polyhydroxy polyurethane protein transfection reagent, preparation method and application thereof

Technical Field

The invention belongs to the technical field of biology, and particularly relates to a polyhydroxy polyurethane protein transfection reagent constructed based on enzymatic-chemical coupling, a preparation method and application thereof in transfection of proteins with molecular weight of 10-450 kDa.

Background

With the rapid development of molecular biology and cell biology, DNA transfection has gradually failed to meet the requirements of scientific research, and protein transfection technology is a supplement to DNA and RNAi transfection and is a powerful tool for protein function research and cell path research. Directly transfecting the protein into the cell not only saves time, but also can be more conveniently applied to the research fields of active protein and polypeptide intracellular interaction, polypeptide library screening, protein half-life determination and the like. However, protein as a natural macromolecule becomes an obstacle to intracellular transfection due to its characteristics of large molecular weight, surface charge loading, easy destruction of high-order structure and the like, and is easily affected by intracellular complex environment after entering cells, and is easily degraded or inactivated. At present, the development of protein drugs and the research on the intracellular functions of proteins are severely restricted by the lack of protein transfection reagents.

In order to more efficiently and safely perform intracellular transfection of proteins, it is highly desirable to develop a class of transfection reagents that can transfect proteins of different molecular weights and different isoelectric points, which reagents are capable of efficiently and safely transfecting unmodified proteins without destroying the higher order structure of the proteins during transfection. The protein transfection reagent produced by Applied Biological Materials, Canada, is composed of a unique cationic lipid-based vector system, and can be used for introducing biologically active proteins, peptide fragments or antibodies into living cells, for transfecting proteins ranging from small polypeptides to proteins exceeding 550kDa, and has a market price of 3200 yuan/250 μ L. The PULSin reagent developed by Polyplus Transfection of France is a novel Transfection reagent that efficiently transfects functional proteins/antibodies into living cells. PULSin is a cationic amphoteric substance, can wrap a plurality of proteins/antibodies through a positive charge coat, successfully solves the problem of protein release in cytoplasm by utilizing an amphoteric endosome release factor, and has the market price of 6000 yuan/400 mu L. To date, protein transfection-based commercialized reagents mainly depend on foreign import and are high in price, and China is still lack of self-developed high-performance commercialized protein transfection reagents. Therefore, the development of a protein transfection reagent with high transfection efficiency and low cost and independent intellectual property rights has important significance in the fields of protein function research, protein drug development and the like.

In the cationic polymer, the polyurethane material is a carrier with a main chain containing a urethane bond, and positive charges contained in the polyurethane material are easily assembled with negatively charged protein or nucleic acid molecules to form a nano-composite and realize efficient cell entry; meanwhile, the amino group contained in the liposome can promote the system to realize the escape of an endosome through a unique 'proton sponge' effect, so that the medicine can be quickly released in cytoplasm; in addition, the material has good biodegradability and safety, and does not cause inflammatory reaction and cytotoxicity of tissues. Therefore, polyurethane and its derivative materials have drawn extensive attention in the biomedical field, especially in the aspects of drug/gene controlled release carriers, biomedical alternative materials, and the like. At present, polyurethane carrier materials are mainly synthesized through a chemical catalysis approach, the synthesis conditions are harsh (high temperature and reduced pressure, no water, no oxygen and the like), the technical route is complex, and the application range of the polyurethane carrier materials is limited by trace residue and potential toxicity of metal catalysts. Compared with the traditional chemical polymerization reaction, the enzymatic polymerization has become a research hotspot in the fields of biocatalysis and biotransformation due to the advantages of mild reaction conditions, environmental friendliness, high stereo and regioselectivity and the like. Moreover, enzymatic polymerization has the following advantages: (1) the high specificity of the substrate can greatly improve the conversion rate of the substrate without generating byproducts; (2) the catalyst can be recycled and reused, which is beneficial to reducing the cost of the synthesis process; (3) enzymatic polymerization can be carried out in solvent-free, aqueous, organic and multiphase interfaces; (4) can effectively catalyze the ring-opening polymerization of compounds such as macrolides and the like which is difficult to realize by an organometallic catalyst; (5) the structure control of the polymer end is easy to realize, and the purposes of modifying and modifying the polymer are achieved. As a new polymerization method, enzymatic polymerization opens up a brand-new and environment-friendly way for the synthesis of high polymer materials, is an effective method for efficiently synthesizing novel functional high polymer materials, and has important significance for promoting the development of chemical and material industries to green and clean directions.

Disclosure of Invention

According to the invention, a polyurethane carrier material is prepared by taking caprolactone, diethyl sebacate and N-methyldiethanolamine as monomers through a mode of coupling enzymatic ring-opening polymerization and polycondensation reaction, the polyurethane material is further modified and modified by utilizing atom transfer radical polymerization reaction, a polyhydroxy polyurethane protein transfection reagent is constructed, and the introduction of hydroxyl is beneficial to improving the interaction of the reagent and a protein drug, so that the assembling and transfection capability of the protein drug is improved. The polyhydroxy polyurethane protein transfection reagent/protein complex obtained by compounding the polyhydroxy polyurethane protein transfection reagent and protein molecules is attached to the surface of a negatively charged cell, enters a lysosome through endocytosis, and releases the loaded protein into cytoplasm through the endosome escape capacity of a polyurethane material. Since the protein and polyhydroxy polyurethane protein transfection reagent form a complex by non-covalent forces, this assembly strategy does not interfere with the structure and biological activity of the protein.

The polyhydroxy polyurethane protein transfection reagent prepared by the invention can transfect proteins with the molecular weight of 10-450 kDa. Superoxide dismutase (SOD), Bovine Serum Albumin (BSA), ribonuclease A (RNase A), granzyme B (GrB) and beta-galactosidase (beta-gal) with different molecular weights are taken as model proteins, a HeLa cell line of a human cervical carcinoma cell is taken as a model cell, and the transfection capability of the synthesized polyhydroxy polyurethane protein transfection reagent is systematically evaluated. The agent can form stable nano-complexes with proteins and successfully deliver proteins with different molecular weights into cytoplasm while maintaining the biological activity of the proteins. The successful delivery of proteins to the fields of research such as intracellular disease therapy, genetic engineering, synthetic biology and the like is of great significance.

The SOD related to the invention has the molecular weight of 32kDa, is derived from bovine red blood cells and is purchased from Beijing Bayer Didy company. The molecular weight of BSA related in the invention is 66.3kDa, and the BSA is prepared by using a heat shock method and purchased from Beijing Jintai Hongda biotechnology limited company. The molecular weight of the RNase A related to the invention is 13.7kDa, is derived from bovine pancreas, can cut RNA molecules in cells, has anti-tumor activity and is purchased from Sigma company in the United states. The molecular weight of GrB related by the invention is 27kDa, and the GrB is expressed in escherichia coli. In the cytoplasm, GrB induces apoptosis through three different pathways, has antitumor activity and is available from the company Cloud-Clone Corp, USA. The beta-gal related by the invention has the molecular weight of 430kDa, is hydrolase in lysosomes of cells, can degrade a substrate of 5-bromo-4-chloro-3-indole-beta-D-galactoside (X-gal) to generate a blue product, is used for intracellular detection of the beta-gal, and is purchased from Sigma company in the United states.

The preparation method of the polyhydroxy polyurethane protein transfection reagent comprises the following steps:

(1) synthesizing a Br-polyester material: weighing 0.4-0.5 g of caprolactone, 2-3 g of diethyl sebacate, 1-2 g of N-methyldiethanolamine and 435100-300 mg of Novozym, dissolving in 5-10 mL of diphenyl ether, and stirring at 80-90 ℃ under 60-70 MPa for 12-24 h to obtain an oligomer, so as to prevent monomers from volatilizing; reacting at 80-85 ℃ under 0.1-0.3 MPa for 48-72 h to obtain polyester; then adding 50-500 mg of bromoisobutyric acid, and reacting for 18-24 h under the conditions of 200-300 MPa and 80-90 ℃ to obtain a crude product; finally, precipitating the crude product in n-hexane, centrifuging, collecting the precipitate, respectively washing for 3-5 times by using dichloromethane and n-hexane, and performing vacuum drying (at 35-40 ℃ for 100-150 min) to obtain Br-polyester;

(2) synthesis of polyhydroxy polyurethane protein transfection reagent: weighing 1-2 mg of copper bromide, 25-30 mu L of pentamethyl diethylenetriamine and 0.8-1.0 g of glycidyl acrylate, and dissolving in 3-5 mL of N, N-dimethylformamide; and (2) purging with nitrogen for 0.5-1 h, sealing, immediately adding 0.1-0.2 mL, 3.5mM ascorbic acid aqueous solution and 100-150 mg Br-polyester, carrying out oil bath reaction at 50-60 ℃ for 2-4 h, adding 1-2 mL ethanolamine, continuing to react for 12-24 h, filtering to remove copper bromide, adding the filtrate into excessive diethyl ether for precipitating a polymer, centrifugally collecting the polymer precipitate, washing dichloromethane and diethyl ether for 3-5 times respectively, and carrying out vacuum drying (35-40 ℃, 100-150 min) to obtain the polyhydroxy polyurethane protein transfection reagent.

The polyhydroxy polyurethane protein transfection reagent is prepared by the method.

The polyhydroxy polyurethane protein transfection reagent can be applied to transfection of proteins with the molecular weight of 10-450 kDa.

Drawings

FIG. 1: 400MHz for polyhydroxy polyurethane protein transfection reagents (top), Br-polyester (middle) and polyester (bottom)¹H NMR spectrum.¹H NMR(CDCl₃，ppm)：1.94(a，(CH₃)₂-)、3.73(b，HOCH₂-)、3.73(c，HOCH₂-)、3.43(d，CH₂NH-)。

FIG. 2: GPC spectra of polyhydroxy polyurethane protein transfection reagents and Br-polyester. Left: polyhydroxy polyurethane protein transfection reagents; and (3) right: br-polyester.

FIG. 3: schematic representation of cytotoxicity of polyhydroxy polyurethane protein transfection reagent on cervical cancer cell line HeLa. The cell viability is plotted on the ordinate.

FIG. 4: transmission electron micrograph of polyhydroxy polyurethane protein transfection reagent/SOD prepared in example 5.

FIG. 5: circular dichroism analysis of SOD and polyhydroxy polyurethane protein transfection reagents/SOD.

FIG. 6: and (3) detecting the endocytosis capacity of the HeLa cells of the polyhydroxy polyurethane protein transfection reagent/FITC-BSA compound under different mass ratios by a fluorescence microscope. (a) The mass ratio is 0; (b) the mass ratio is 1; (c) the mass ratio is 2; (d) the mass ratio is 4; (e) the mass ratio is 6; (f) the mass ratio is 8; (g) the mass ratio is 10; (h) the mass ratio is 12; (i) mass ratio is 16; (j) the mass ratio was 20. The scale bar is 200 μm.

FIG. 7: and detecting the positioning condition of the polyhydroxy polyurethane protein transfection reagent/FITC-BSA compound at different times after entering the HeLa cells by using a laser confocal microscope. DAPI: cell nucleus; FITC: FITC-BSA; LysoTracker Red: lysosomes.

FIG. 8: HeLa cell endocytosis map of polyhydroxy polyurethane protein transfection reagent/FITC-RNase A complex was examined by fluorescence microscopy. (a) FITC-RNase A; (b) polyhydroxy polyurethane protein transfection reagent/FITC-RNase A.

FIG. 9: schematic diagram of the capability of polyhydroxy polyurethane protein transfection reagent/RNase A compound on inhibiting HeLa proliferation of cervical cancer cell lines. The cell viability is plotted on the ordinate.

FIG. 10: flow cytometry analysis of HeLa cell endocytosis capacity quantitative map of polyhydroxy polyurethane protein transfection reagent/FITC-GrB complex with different mass ratios.

FIG. 11: schematic diagram of the ability of polyhydroxy polyurethane protein transfection reagent/GrB complex to inhibit HeLa proliferation of cervical cancer cell line. The cell viability is plotted on the ordinate.

FIG. 12: fluorescence microscopy detection of HeLa cell endocytosis of polyhydroxy polyurethane protein transfection reagent/beta-gal complex in an effort: (a) beta-gal, (b) polyhydroxy polyurethane protein transfection reagent/beta-gal.

Detailed Description

The following examples are presented to further illustrate the present invention and to provide those skilled in the art with a more complete understanding of the invention. The examples given are not to be construed as limiting the scope of the invention and thus insubstantial modifications and adaptations of the invention by those skilled in the art based on the teachings set forth herein are intended to be covered thereby.

Example 1

(1) Synthesizing a Br-polyester material: 0.45g of caprolactone, 2.5g of diethyl sebacate, 1g of N-methyldiethanolamine and 200mg of Novozym 435 (immobilized Candida antarctica lipase B, from Novitin, Denmark) were weighed into 7mL of diphenyl ether and added to a 25mL round bottom reaction flask, which was then connected to a digital vacuum regulator-controlled vacuum line. Setting reaction conditions: in the first stage, stirring is carried out for 24 hours at the temperature of 85 ℃ under the pressure of 60MPa to obtain oligomer, so that the monomer is prevented from volatilizing; in the second stage, the polyester is obtained after reaction for 72 hours at the temperature of 85 ℃ and under the pressure of 0.1 MPa; in the third stage, 200mg of bromoisobutyric acid is added and the reaction is carried out for 24h under the conditions of 200MPa and 85 ℃. And finally, precipitating the crude product in n-hexane, centrifuging, collecting the precipitate, respectively washing the precipitate for 3 times by using dichloromethane and the n-hexane, and drying the precipitate in vacuum (37 ℃ and 120min) to obtain Br-polyester, wherein the mass of the product is 1.86 g.

(2) Synthesis of polyhydroxy polyurethane protein transfection reagent: weighed copper bromide 1.5mg, pentamethyldiethylenetriamine 25. mu.L and glycidyl acrylate 1g were dissolved in 4mL of N, N-dimethylformamide, and added to a 10 mL-necked flask, which was purged with nitrogen for 1 hour and then sealed. Then 0.1mL of 3.5mM ascorbic acid in water and 100mg of Br-polyester were immediately added, the reaction was carried out in an oil bath at 55 ℃ for 3 hours, 1mL of ethanolamine was further added to continue the reaction for 24 hours, copper bromide was removed by filtration, and the filtrate was added to an excess of ether to effect precipitation of the polymer. The polymer was collected by centrifugation, washed 3 times with dichloromethane and ether respectively, and dried under vacuum (37 ℃ C., 120min) to give the polyhydroxyurethane protein transfection reagent in a mass of 53.26 mg.

Example 2

The structural characterization of the polyhydroxy polyurethane protein transfection reagent comprises the following specific processes: weighing 1mg of polyhydroxy polyurethane protein transfection reagent, polyester material and Br-polyester material, dissolving with deuterated chloroform, and making use of the solution at 400MHz¹H NMR (Bruker Avance III NMR spectrometer) characterized the structure of the polyhydroxy polyurethane protein transfection reagent. The results are shown in figure 1, for the polyhydroxy polyurethane protein transfection reagent, the signals at δ -3.64 and 1.94ppm correspond to methylene groups adjacent to the hydroxyl group and methyl groups adjacent to Br, and the new peak δ -3.43 ppm is considered to be the methyl group attached to the hydroxyl groupProtons, the above results demonstrate the successful synthesis of polyhydroxy polyurethane protein transfection reagents. Gel permeation chromatography was performed on a marvin 515 hplc equipped with a marvin 410RI detector and agilent PLgel MIXED-D column using tetrahydrofuran as eluent at a flow rate of 1.0mL/min and a temperature of 35 ℃, and the detection was calibrated with narrow molecular weight distribution polystyrene standards, the results are shown in fig. 2. The number average molecular weights of the polyhydroxy polyurethane protein transfection reagent and Br-polyester were 13120 and 6670g/mol, respectively. Furthermore, the polydispersity number of the polyhydroxy polyurethane protein transfection reagent was 1.268, which is lower than Br-polyester (1.541), and also demonstrates the successful synthesis of polyhydroxy polyurethane protein transfection reagent with more uniform molecular weight distribution.

Example 3

The toxicity detection process of the polyhydroxy polyurethane protein transfection reagent is as follows: according to 8X 10³Per well inoculum size human cervical carcinoma cells HeLa were inoculated into 96-well plates, the volume of the medium in each well was supplemented to 200. mu.L with DMEM cell medium (complete medium) containing 10% fetal bovine serum, 100U/mL penicillin, 100U/mL streptomycin, and the 96-well plates were placed at 37 ℃ with 5% CO₂Culturing in a cell culture box, carefully discarding the culture medium when the cell confluence is more than 70%, adding 200 mu L of polyhydroxy polyurethane protein transfection reagent samples (0-100 mu g/mL) prepared by DMEM culture medium with different concentrations, additionally arranging a negative control group (only adding DMEM culture medium) and a blank control group, and arranging 6 duplicate wells in each group. The incubation was continued for 24h after the addition of the sample treatment, then 20. mu.L of MTT solution (5mg/mL) was added to each well, the incubation was continued for 4h at 37 ℃ and the medium was carefully discarded, then 200. mu.L of dimethyl sulfoxide was added to each well, shaking was carried out for 5min, and the absorbance value at 490nm was measured for each well using a microplate reader. Cell viability was calculated using the following formula:

cell survival rate (%) ═ a_sample-A_blank)/(A_control-A_blank)×100％

Wherein A is_sampleRespectively measuring absorbance values after adding polyhydroxy polyurethane protein transfection reagents with different concentrations, A_controlFor the normal culture of cells in DMEM mediumAbsorbance value measured after cells, A_blankAbsorbance values determined after adding only DMEM cell culture medium for cell-free.

As shown in figure 3, the proliferation inhibition capacity of human cervical carcinoma cells HeLa is not obviously changed along with the increase of the concentration of the polyhydroxy polyurethane protein transfection reagent, the cell survival rate is still maintained to be more than 75% when the concentration of the reagent is 100 mug/mL, and the results show that the polyhydroxy polyurethane protein transfection reagent has low cytotoxicity and good biomedical application prospect.

Example 4

Synthesis of FITC-labeled protein molecules: 100mg of BSA, RNase A, SOD, GrB and 25mg of Fluorescein Isothiocyanate (FITC) were dissolved in 30mL of phosphate buffer (50mM, pH 8.0), respectively, and the sample was stirred at 180rpm under a dark condition at 4 ℃ for 24 hours. The sample was then dialyzed in phosphate buffer (50mM, pH 8.0) for 3 days (molecular weight cut-off: 3500Da), the dialysate was changed every 12h, and after completion of dialysis, lyophilized to obtain FITC-labeled protein molecules.

Example 5

Preparation of polyhydroxy polyurethane protein transfection reagent/protein complex: respectively and uniformly mixing the polyhydroxy polyurethane protein transfection reagent (40 mu g) and different protein molecules (BSA, RNase A, SOD and GrB, 5 mu g) in a serum-free DMEM culture medium, standing and incubating for 30min at 37 ℃ to obtain the polyhydroxy polyurethane protein transfection reagent/protein complex, and storing for later use.

Preparing protein complex of FITC labeled polyhydroxy polyurethane protein transfection reagent: respectively mixing polyhydroxy polyurethane protein transfection reagent (40 mu g) and multiple protein molecules (BSA, RNase A, SOD, GrB, 5 mu g) marked by FITC in serum-free DMEM medium, standing and incubating for 30min at 37 ℃ to obtain the polyhydroxy polyurethane protein transfection reagent/protein complex marked by FITC, and storing for later use.

Example 6

The polyhydroxy polyurethane protein transfection reagent/SOD complex prepared in example 5 was coated on a 300 mesh carbon film coated copper mesh and allowed to air dry naturally at room temperature. The copper mesh coated with the protein complex was examined by JEM-2100 transmission electron microscope (Japan Electron Ltd.) at an acceleration voltage of 200 kV. As shown in FIG. 4, it can be clearly observed that the polyhydroxy polyurethane protein transfection reagent/SOD complex is spherical with a particle size of about 180 nm.

Example 7

The instrument used for detecting the secondary structure of the sample is a J-810 type circular dichroism chromatograph, 1mg of the polyhydroxy polyurethane protein transfection reagent/SOD protein compound prepared in the example 5 is dissolved in 1mL of ultrapure water, and after the polyhydroxy polyurethane protein transfection reagent/SOD protein compound is fully dissolved, the circular dichroism chromatograph is used for analyzing the secondary structure, and the molar ellipsoid rate of the protein compound at 190-250nm is detected. As shown in fig. 5, the SOD molecules of the polyhydroxy polyurethane protein transfection reagent/SOD protein complex retained intact secondary structures compared to free SOD molecules, indicating that the assembly of polyhydroxy polyurethane protein transfection reagent and SOD molecules did not affect the higher order structure of SOD molecules.

Example 8

Detecting endocytosis of FITC labeled polyhydroxy polyurethane protein transfection reagent/BSA complex by a fluorescence microscope according to 2.0X 10⁵Inoculation amount of Perwell human cervical cancer cell HeLa cell was inoculated into 6-well plate, each well was supplemented to 2mL with complete medium, 6-well plate was placed at 37 ℃ with 5% CO₂Culturing in a cell culture box for 12 h. The supernatant was carefully discarded, and polyhydroxy polyurethane protein transfection reagent/FITC-BSA complex (mass ratio from 0 to 20) was prepared in different mass ratios according to the preparation method of example 5, added to the culture system, and after further culturing for 6 hours, washed 2 times with phosphate buffer (50mM, pH 7.4), observed with IX73P1F fluorescence microscope (olympus) and photographed. As shown in fig. 6, as the mass ratio of polyhydroxy polyurethane protein transfection reagent/BSA was increased, the cell-entering efficiency of BSA was also significantly improved; after a mass ratio of more than 8, the efficiency of BSA entry into the cell began to decrease, probably due to the high density of positive charges of the reagents themselves. The above results show that the polyhydroxy polyurethane protein transfection reagent can successfully mediate intracellular transfection of BSA molecules, and that the optimal transfection efficiency is achieved when the polyhydroxy polyurethane protein transfection reagent/BSA mass ratio is 8.

Example 9

And (3) observing the positioning condition of the FITC-labeled polyhydroxy polyurethane protein transfection reagent/BSA complex at different times after the complex is endocytosed into HeLa cells by a confocal laser microscope: HeLa cells for human cervical cancer at 2.0X 10⁵The density of the/hole is inoculated on a cover glass which is pretreated and is placed in the hole of a six-hole plate (the cover glass is soaked in concentrated acid solution for 48 hours, then soaked in distilled water and autoclaved), the cover glass is incubated for 24 hours at 37 ℃ and then is changed into a serum-free culture medium, a polyhydroxy polyurethane protein transfection reagent/FITC-BSA compound labeled by FITC is added, after 2 hours, 4 hours, 6 hours and 12 hours of culture, the culture solution is discarded, a lysosome dye LysoTracker Red and a nuclear dye 4', 6-diamidino-2-phenylindole (DAPI) are added for staining for 30 minutes, PBS is washed for 5 times, then 1mL of 75% glacial ethanol is added for fixing for 30 minutes, and the PBS is washed for three times. The slide was mounted with glycerol phosphate buffer (v/v:9:1) and stored at 4 ℃ in the dark. Photographs were observed using an LSM710 confocal laser microscope (Calzaisi, Germany) at laser wavelengths of 590nm, 488nm, and 461nm for LysoTracker Red, FITC, and DAPI, respectively. For each channel and field of view, the laser intensity, photomultiplier gain, and compensation are readjusted to obtain the optimum signal/noise ratio. The results were finally analyzed with the software Zen 2009Light Edition (Carl Zeiss, germany). The results are shown in FIG. 7, at 2-6h, the green fluorescence of FITC-BSA and the red fluorescence of the lysosomal dye were completely co-localized, indicating that the polyhydroxy polyurethane protein transfection reagent/BSA complex achieved entry by endocytosis; 12h after entering HeLa cells, the green fluorescence was separated from the red fluorescence, indicating that the polyhydroxy polyurethane protein transfection reagent/BSA complex was released from lysosomes and entered the cytosol. The results show that the polyhydroxy polyurethane protein transfection reagent can mediate BSA molecules to realize lysosome escape, so that protein molecules are better protected from degradation in acidic and enzyme environments, and ideal transfection efficiency is achieved.

Example 10

Fluorescence microscopy of the endocytosis of FITC-labeled polyhydroxy polyurethane protein transfection reagent/RNase A complex: according to 2.0X 10⁵The inoculation amount of each well is that HeLa cells of human cervical carcinoma cells are inoculated into a 6-well plate, each well is supplemented to 2mL by complete culture medium,placing the 6-well plate at 37 deg.C and 5% CO₂After 12 hours of incubation in a cell incubator, the supernatant was carefully discarded, and the FITC-labeled polyhydroxy polyurethane protein transfection reagent/RNase a complex prepared in example 5 was added to the culture system, and after further incubation for 6 hours, the system was washed 2 times with phosphate buffer (50mM, pH 7.4), observed with an IX73P1F fluorescence microscope (olympus) and photographed. As shown in FIG. 8, free FITC-RNase A cannot enter cells, and a large amount of green fluorescence can be observed inside the cells after the polyhydroxy polyurethane protein transfection reagent/FITC-RNase A compound is used for treating the cells, which indicates that the polyhydroxy polyurethane protein transfection reagent can successfully realize the assembly of RNase A and realize the efficient transfection of RNase A.

Example 11

The detection process for inhibiting the proliferation of the human cervical carcinoma cells by the polyhydroxy polyurethane protein transfection reagent/RNase A compound is as follows: according to 8X 10³Per well inoculum HeLa cells were seeded into 96-well plates, each well was replenished to 200. mu.L with complete cell culture medium, and the 96-well plates were placed at 37 ℃ in 5% CO₂Culturing in a cell culture box. When the cell confluence is more than 70%, the culture medium is carefully discarded, and 200 μ L of polyhydroxy polyurethane protein transfection reagent prepared by DMEM medium, free RNase A and polyhydroxy polyurethane protein transfection reagent/RNase A complex are respectively added. The concentration of RNase A was 1. mu.g/mL, 2. mu.g/mL, 3. mu.g/mL, 4. mu.g/mL and 5. mu.g/mL, respectively, and a negative control group (DMEM medium alone) and a blank control group were additionally provided, each group having 6 duplicate wells. The incubation was continued for 24h after the addition of the sample treatment, then 20. mu.L of MTT solution (5mg/mL) was added to each well, the incubation was continued for 4h at 37 ℃ with care to discard the medium, then 200. mu.L of dimethyl sulfoxide was added to each well, shaking for 5min, and the absorbance at 492nm per well was measured with a microplate reader. Cell viability was calculated using the following formula:

cell survival rate (%) ═ a_sample-A_blank)/(A_control-A_blank)×100％

Wherein A is_sampleRespectively measuring absorbance values after adding polyhydroxy polyurethane protein transfection reagent, free RNase A and polyhydroxy polyurethane protein transfection reagent/RNase A compound，A_controlAbsorbance values measured after normal cell culture in DMEM medium, A_blankAbsorbance values determined after adding only DMEM cell culture medium for cell-free.

As shown in FIG. 9, the polyhydroxy polyurethane protein transfection reagent/RNase A compound can obviously inhibit proliferation of human cervical carcinoma cells HeLa, while the proliferation inhibition capability of free RNase A and polyhydroxy polyurethane protein transfection reagents on HeLa cells has no obvious change, which indicates that the polyhydroxy polyurethane protein transfection reagent can realize high-efficiency transfection of RNase A molecules, maintain the biological activity of the polyhydroxy polyurethane protein transfection reagents and play a role in killing tumor cells.

Example 12

The endocytosis of the FITC-labeled polyhydroxy polyurethane protein transfection reagent/GrB complex was analyzed by flow cytometry: according to 2.0X 10⁵Inoculation amount of per well human cervical cancer cell HeLa cells were inoculated into 6-well plates, each well was replenished to 2mL with complete medium, 6-well plates were placed at 37 ℃ with 5% CO₂After 12 hours of incubation in a cell incubator and careful removal of the supernatant, the FITC-labeled polyhydroxyurethane protein transfection reagent/GrB complex prepared in example 5 was added to the culture system, and after further incubation for 6 hours, the cells were washed 2 times with phosphate buffer (50mM, pH 7.4), digested with 0.25% trypsin for 2min, collected, washed 2 times with pre-cooled PBS, and the fluorescent signal in HeLa cells was detected by flow cytometry. As shown in fig. 10, as the mass ratio of polyhydroxy polyurethane protein transfection reagent/GrB gradually increased, the GrB entry efficiency significantly increased, indicating that the polyhydroxy polyurethane protein transfection reagent has good ability to mediate GrB transfection.

Example 13

The detection process for inhibiting human cervical carcinoma cell proliferation by the polyhydroxy polyurethane protein transfection reagent/GrB compound is as follows: according to 8X 10³Per well inoculum HeLa cells were seeded into 96-well plates, each well was replenished to 200. mu.L with complete cell culture medium, and the 96-well plates were placed at 37 ℃ in 5% CO₂Culturing in a cell culture box. When the cell confluence is more than 70%, carefully discarding the culture medium, and respectively adding 200 μ L of polyhydroxy polyurethane egg prepared by DMEM culture mediumWhite matter transfection reagent, free GrB and polyhydroxy polyurethane protein transfection reagent/GrB complex, and a negative control group (only adding DMEM culture medium) and a blank control group are additionally arranged, and each group is provided with 6 multiple wells. The incubation was continued for 24h after the addition of the sample treatment, then 20. mu.L of MTT solution (5mg/mL) was added to each well, the incubation was continued for 4h at 37 ℃ with care to discard the medium, then 200. mu.L of dimethyl sulfoxide was added to each well, shaking was carried out for 5min, and the absorbance at 492nm per well was measured using a microplate reader. Cell viability was calculated using the following formula:

cell survival rate (%) ═ a_sample-A_blank)/(A_control-A_blank)×100％

Wherein A is_sampleRespectively, measured absorbance values after adding polyhydroxy polyurethane protein transfection reagent, free GrB and polyhydroxy polyurethane protein transfection reagent/GrB complex, A_controlAbsorbance values measured after normal cell culture in DMEM medium, A_blankAbsorbance values determined after adding only DMEM cell culture medium for cell-free. As shown in FIG. 11, the cell survival rate of HeLa cells is not significantly affected by free GrB molecules and polyhydroxy polyurethane protein transfection reagents, while the proliferation inhibition ability of polyhydroxy polyurethane protein transfection reagents/GrB complexes on human cervical cancer cells HeLa is significantly increased, and the results show that the polyhydroxy polyurethane protein transfection reagents can realize efficient transfection of GrB molecules after being assembled with GrB, maintain the biological activity in cells and play an anti-tumor role.

Example 14

Detecting the endocytosis condition of the polyhydroxy polyurethane protein transfection reagent/beta-gal complex by a fluorescence microscope: according to 2.0X 10⁵Inoculation amount of Perwell human cervical cancer cell HeLa cell was inoculated into 6-well plate, each well was supplemented to 2mL with complete medium, 6-well plate was placed at 37 ℃ with 5% CO₂After 12 hours of incubation in a cell incubator, the supernatant was carefully discarded, the polyhydroxy polyurethane protein transfection reagent/β -gal complex prepared in example 5 was added to the culture system, and after 12 hours of incubation, the system was washed 2 times with phosphate buffer (50mM, pH 7.4), and 1mL of β -galactosidase staining fixative was added and fixed at room temperature for 10 min. Suction removalThe cells were fixed and washed 3 times for 3min with phosphate buffered saline (50mM, pH 7.4). Add 1mL of X-gal working solution to each well, incubate at 37 ℃ for 2h, observe with IX73P1F fluorescence microscope (Olympus) and take pictures. As shown in FIG. 12, free beta-gal molecules cannot enter cells, no blue substance is observed inside the cells, and the polyhydroxy polyurethane protein transfection reagent is transfected after being assembled with the beta-gal molecules, and a large amount of blue substance is observed inside the cells, which indicates that the polyhydroxy polyurethane protein transfection reagent has good protein transfection capability, can realize high-efficiency cell entry of the beta-gal molecules, and can exert the biological functions thereof.

Claims

1. A preparation method of polyhydroxy polyurethane protein transfection reagent comprises the following steps:

(1) synthesizing a Br-polyester material: weighing 0.4-0.5 g of caprolactone, 2-3 g of diethyl sebacate, 1-2 g of N-methyldiethanolamine and 435100-300 mg of Novozym, dissolving in 5-10 mL of diphenyl ether, and stirring at 80-90 ℃ under 60-70 MPa for 12-24 h to obtain an oligomer, so as to prevent monomers from volatilizing; reacting at 80-85 ℃ under 0.1-0.3 MPa for 48-72 h to obtain polyester; then adding 50-500 mg of bromoisobutyric acid, and reacting for 18-24 h under the conditions of 200-300 MPa and 80-90 ℃ to obtain a crude product; finally, precipitating the crude product in n-hexane, centrifuging, collecting the precipitate, respectively washing for 3-5 times by using dichloromethane and the n-hexane, and drying in vacuum to obtain Br-polyester;

(2) synthesis of polyhydroxy polyurethane protein transfection reagent: weighing 1-2 mg of copper bromide, 25-30 mu L of pentamethyl diethylenetriamine and 0.8-1.0 g of glycidyl acrylate, and dissolving in 3-5 mL of N, N-dimethylformamide; and purging with nitrogen for 0.5-1 h, sealing, immediately adding 0.1-0.2 mL, 3.5mM ascorbic acid aqueous solution and 100-150 mg Br-polyester, performing oil bath reaction at 50-60 ℃ for 2-4 h, adding 1-2 mL ethanolamine, continuing to react for 12-24 h, filtering to remove copper bromide, adding the filtrate into excessive diethyl ether for polymer precipitation, centrifugally collecting polymer precipitate, washing with dichloromethane and diethyl ether for 3-5 times respectively, and performing vacuum drying to obtain the polyhydroxy polyurethane protein transfection reagent.

2. The method of claim 1, wherein the polyhydroxy polyurethane protein transfection reagent is prepared by the following steps: the temperature of vacuum drying is 35-40 ℃, and the time of vacuum drying is 100-150 min.

3. A polyhydroxy polyurethane protein transfection reagent, characterized in that: is prepared by the method of claim 1 or 2.

4. Use of the polyhydroxy polyurethane protein transfection reagent of claim 3 to transfect proteins.

5. The use of the polyhydroxy polyurethane protein transfection reagent of claim 4 in transfecting proteins, wherein: the molecular weight of the protein is 10-450 kDa.

6. The use of polyhydroxy polyurethane protein transfection reagent according to claim 5 in transfecting proteins, wherein: the protein is superoxide dismutase, bovine serum albumin, ribonuclease A, granzyme B or beta-galactosidase.